Saturday 7 November 2026
Export HCA’s income statement to Excel — free account
HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024.
- Revenue
- +3.59%
- EPS
- +23.8%
- Free cash flow
- −0.77%
- Total debt
- +13.4%
Quarter to September 2026, against a year earlier
496.04
11.44
−2.25%
Follow HCA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 8 | 8 | 7 |
| (612.27%) | (397.78%) | (307.62%) | (200.53%) | ||
| 11.28% | 11.21% | 11.14% | 11.00% | ||
ROIC |
17.64% | 17.06% | 16.68% | 16.84% | |
Return on Tangible Assets |
22.19% | 24.04% | 21.58% | 23.60% | |
Average Days of Receivables |
52.47 | 54.11 | 57.46 | 53.38 | |
Free Cash Flow per Share |
32.54 | 35.45 | 27.19 | 27.83 | |
Free Cash Flow |
7,692.00 | 7,927.00 | 5,997.00 | 5,973.00 | |
Capital Expenditures |
(4,944.00) | (5,072.00) | (5,127.00) | (5,196.00) | |
| Other line items | |||||
Cash ROIC |
17.18% | 17.24% | 12.62% | 12.76% | |
Accounts Receivable Turnover |
6.99 | 6.82 | 6.86 | 7.18 | |
Accounts Payable Turnover |
2.54 | 2.47 | 2.55 | 2.39 | |
Inventory Turnover |
6.71 | 6.59 | 6.66 | 6.78 | |
Average Days of Payables |
149.60 | 153.12 | 150.85 | 161.43 | |
Days of Inventory on Hand |
53.05 | 53.56 | 52.76 | 52.83 | |
Tax Rate |
(0.21) | (0.20) | (0.20) | (0.21) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
43.46% | 43.39% | 42.68% | 42.58% | |
Share Based Compensation of Revenue |
0.53% | 0.51% | 0.48% | 0.51% | |
Interest Coverage |
5.36 | 5.27 | 5.24 | 5.13 | |
Operating CF/Net income |
1.86 | 1.91 | 1.63 | 1.65 | |
Depreciation/Fixed assets |
0.11 | 0.12 | 0.12 | 0.12 | |
Capex/Depreciation |
(1.39) | (1.39) | (1.38) | (1.37) | |
Revenue per Share |
319.78 | 341.65 | 353.74 | 366.75 | |
Operating CF per Share |
53.45 | 58.14 | 50.44 | 52.05 | |
Capex per Share |
(20.91) | (22.68) | (23.25) | (24.21) | |
Capex to Sales |
0.07 | 0.07 | 0.07 | 0.07 |
Columns are period end dates · fundamentals updated 2 Nov 2026